Peter D. Haytaian

This profile gathers the share dealings of Peter D. Haytaian in Elevance Health, Inc., where the filings describe the role as chief executive. Between 31 October 2018 and 2 March 2026, the trades on record add up to 11 filings.

Every open-market trade on record is a sale: 1 sale worth €238k. Besides market trades, the filings include 9 share grants and 1 option exercise.

Most recently, on 4 March 2026, the filings show a share grant worth €300k in Elevance Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.